| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8217184 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 6 Pages |
Abstract
Low-dose (10-Gy) TSEBT offers a high overall response rate and is relatively safe. With this approach, reirradiation at times of relapse or progression is likely to be less toxic than standard dose TSEBT. It remains to be established whether adjuvant and combination treatments can prolong the beneficial effects of low-dose TSEBT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Maria R. PhD, MD, Robert DMSc, PhD, MD, Lars DMSc, MD, Lone DMSc, PhD, MD, Peter Meidahl DMSc, PhD, MD, Annika DMSc, MD, Lena DMSc, MD,